Akela Pharma Inc. and PharmaForm LLC Expand Drug Formulation and Manufacturing Capabilities
11/4/2009 12:12:54 PM
More...
|
Akela Pharma Inc. to Cut Staff by 33 Percent, to Close Sites
9/3/2009 6:41:17 AM
More...
|
Akela Pharma Inc. Announces New CEO
9/2/2009 6:45:01 AM
More...
|
Akela Pharma Inc. Appoints New Board of Directors
6/26/2009 11:43:52 AM
More...
|
Akela Pharma Inc. and Nventa Biopharmaceuticals Corporation (NVN.TO) Announce Closing of Merger
5/22/2009 7:08:44 AM
More...
|
Akela Pharma Inc. to Buy Nventa Biopharmaceuticals Corporation (NVN.TO) in Stock Deal Worth C $1.4 Million
3/27/2009 7:10:50 AM
More...
|
Akela Pharma Inc. to Cut Costs to Sustain Long-Term Viability of the Company
2/9/2009 6:41:16 AM
More...
|
Akela Pharma Inc. Announces Achievement of Third Fentanyl TAIFUN(R) Phase 3 Study Related Milestone
1/13/2009 10:43:10 AM
More...
|
Akela Pharma Inc. Reports Results for the Third Quarter of Fiscal 2008
11/14/2008 4:33:43 PM
More...
|
Akela Pharma Inc. Announces Approval to Initiate Fentanyl TAIFUN(R) Phase 3 Study in Europe and Initiation of Clinical Program in Japan
9/4/2008 3:04:19 PM
More...
|
|